🇺🇸 FDA
Patent

US 10806697

Vaginal inserted estradiol pharmaceutical compositions and methods

granted A61KA61K31/565A61K47/14

Quick answer

US patent 10806697 (Vaginal inserted estradiol pharmaceutical compositions and methods) held by Compass Therapeutics LLC expires Mon Oct 15 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Compass Therapeutics LLC
Grant date
Tue Oct 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 15 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/565, A61K47/14, A61K9/0036, A61K9/4858